Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Energyo Solutions Russia AB in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Energyo Solutions Russia AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Energyo Solutions Russia AB | - | - | - | - | - | - | - |
| Mainova AG | -1.610% | 8.152% | 11.798% | 13.068% | 17.059% | -17.769% | -28.288% |
| Ocean Power Technologies Inc. | -22.910% | -0.958% | 8.317% | -31.582% | 27.476% | -36.385% | -83.402% |
| Nippon Gas Co. Ltd | -0.690% | -3.333% | -2.027% | -7.051% | -8.228% | 14.173% | - |
News
Why Did Eos Energy Stock Soar Again on Tuesday?
Shares of Eos Energy Enterprises (NASDAQ: EOSE) surged on Tuesday, rallying 13% in early morning trading and closing the day up 8.3%.
This company has developed zinc-based battery energy storage
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data
Key Points
- Interested in IDEAYA Biosciences, Inc.? Here are five stocks we like better.
- IDEAYA Biosciences said its lead melanoma drug, darovasertib, is on track for an NDA submission after
Bullish Q1 Earnings Call Highlights
Bullish (NYSE:BLSH) executives used the company’s first-quarter 2026 earnings call to frame its planned acquisition of Equiniti